CONMED Corporation Announces Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street wavers as Federal Reserve holds key rate steady, pending more data
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Conmed (CNMD) Tops Q2 EPS by 1c; Lowers FY22 Guidance
July 27, 2022 4:32 PM EDTConmed (NYSE: CNMD) reported Q2 EPS of $0.76, $0.01 better than the analyst estimate of $0.75. Revenue for the quarter came in at $277.2 million versus the consensus estimate of $274.25 million.
GUIDANCE:
Due to changes in foreign exchange rates, the Company is... More



